Abstract
Background Mild obstructive sleep (OSA) is a common disorder associated with daytime sleepiness and impaired quality of life. Given that adherence to positive airway pressure (PAP) therapy in OSA is suboptimal, alternative strategies are needed particularly for patients with mild OSA. Daytime neuromuscular electrical stimulation (NMES) of the tongue is a new therapeutic modality for mild OSA. The objective of this study was to determine if patients with mild OSA adhere to daytime NMES.
Methods A randomized sham-controlled double-masked controlled trial was conducted in 40 patients with mild OSA who received either high intensity (active) or low intensity (sham) NMES for 6-weeks. The primary endpoint was adherence to therapy. Exploratory outcomes included the respiratory event index (REI) and the Epworth Sleepiness Scale (ESS) score.
Results More than 90% of participants in each arm were adherent to NMES. Exploratory analyses revealed a 32.7% (95% CI: 15.5%, 49.9%) drop in REI with active NMES, with no significant change the REI with sham NMES. Improvements were larger in the supine than non-supine REI. Both the apnea index and hypopnea index improved with active NMES. Finally, the ESS score improved with active but not with sham NMES.
Interpretation Daytime NMES was well accepted, with a majority using it for the recommended period. NMES of the tongue use was associated with improvements in OSA severity and daytime sleepiness. Additional research is needed to define its role in the treatment armamentarium across the spectrum of OSA severity and in patients who are intolerant to PAP therapy.
Footnotes
This manuscript has recently been accepted for publication in the ERJ Open Research. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJOR online. Please open or download the PDF to view this article.
Conflict of interest: Alexandre R Abreu has nothing to disclose.
Conflict of interest: Darko Stefanovski has nothing to disclose.
Conflict of interest: Susheel P. Patil has nothing to disclose.
Conflict of interest: Trishul Siddharthan has nothing to disclose.
Conflict of interest: Alejandro Chediak has nothing to disclose.
Conflict of interest: Douglas M. Wallace has nothing to disclose.
Conflict of interest: M. Punjabi has nothing to disclose.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received July 13, 2023.
- Accepted October 11, 2023.
- Copyright ©The authors 2023
This version is distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. For commercial reproduction rights and permissions contact permissions{at}ersnet.org